Dose optimisation for Loss of Response to Vedolizumab— Pharmacokinetics and Immune Mechanisms.

Autor: Ungar, Bella¹ (AUTHOR) bellageyshis@gmail.com, Malickova, Karin² (AUTHOR), Hanžel, Jurij³ (AUTHOR), Arisha, Muhammad Abu⁴ (AUTHOR), Paul, Stephane⁵ (AUTHOR), Rocha, Catia^6,7 (AUTHOR), Shatach, Zohar Ben¹ (AUTHOR), Abitbol, Chaya Mushka¹ (AUTHOR), Natour, Ola Haj¹ (AUTHOR), Selinger, Limor¹ (AUTHOR), Yavzori, Miri¹ (AUTHOR), Fudim, Ella¹ (AUTHOR), Picard, Orit¹ (AUTHOR), Shoval, Irit⁸ (AUTHOR), Eliakim, Rami¹ (AUTHOR), Kopylov, Uri¹ (AUTHOR), Magro, Fernando⁶ (AUTHOR), Roblin, Xavier⁹ (AUTHOR), Chowers, Yehuda⁴ (AUTHOR), Drobne, David^3,10 (AUTHOR)

Publikováno v: Journal of Crohn's & Colitis. Oct2021, Vol. 15 Issue 10, p1707-1719. 13p.

Biomarkers in critically ill patients with systemic inflammatory response syndrome or sepsis supplemented with high-dose selenium

Autor: Brodska, Helena, Valenta, Jiri, Malickova, Karin, Kohout, Pavel, Kazda, Antonin, Drabek, Tomas

Publikováno v: In Journal of Trace Elements in Medicine and Biology July 2015 31:25-32

Avidity of anticardiolipin antibodies—A factor that could be important for their detection by ELISA methods

Autor: Fialová, Lenka, Malbohan, Ivan, Malíčková, Karin

Publikováno v: In Journal of Applied Biomedicine November 2014 12(4):277-284

Relationship of Anti-vimentin antibodies to anti-endothelial antibodies

Autor: Malickova Karin, Janatkova Ivana, Sandova Petra, Fucikova Terezie

Publikováno v: Open Medicine, Vol 1, Iss 3, Pp 228-236 (2006)

Externí odkaz: https://doaj.org/article/139e291434184a95a63048e6378a8d85

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.